• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有广泛耐药结核病的幼儿的长期利奈唑胺治疗

Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.

作者信息

Schaaf H Simon, Willemse Marianne, Donald Peter R

机构信息

Department of Paediatrics and Child Health, Stellenbosch University and Tygerberg Children's Hospital, Cape Town, South Africa.

出版信息

Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491.

DOI:10.1097/INF.0b013e31819bc491
PMID:19633523
Abstract

Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.

摘要

广泛耐药结核病(XDR-TB)的治疗是一项挑战。我们描述了一名患有肺部XDR-TB的幼儿,其对积极的耐多药结核病治疗方案无反应,但通过利奈唑胺联合其他备用抗结核药物治愈。在XDR-TB的19个月治疗期间未观察到严重不良事件。

相似文献

1
Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.一名患有广泛耐药结核病的幼儿的长期利奈唑胺治疗
Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491.
2
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.阿根廷采用利奈唑胺、莫西沙星和硫利达嗪联合治疗广泛耐药结核病取得成功。
J Antimicrob Chemother. 2012 Feb;67(2):473-7. doi: 10.1093/jac/dkr500. Epub 2011 Dec 1.
3
Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.每日半剂量利奈唑胺治疗难治性耐多药结核病患者的疗效及耐受性
J Antimicrob Chemother. 2006 Sep;58(3):701-4. doi: 10.1093/jac/dkl298. Epub 2006 Jul 19.
4
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.每日半剂量利奈唑胺治疗难治性耐多药结核病。
Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.
5
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
6
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.每日300毫克利奈唑胺剂量用于治疗难治性耐多药和广泛耐药结核病。
J Antimicrob Chemother. 2009 Aug;64(2):388-91. doi: 10.1093/jac/dkp171. Epub 2009 May 25.
7
Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit.利奈唑胺治疗儿童耐多药/广泛耐药结核病:一家儿童传染病科的经验
Scand J Infect Dis. 2011 Jul;43(6-7):556-9. doi: 10.3109/00365548.2011.564649. Epub 2011 Mar 10.
8
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.利奈唑胺:一种有效的、安全的、廉价的药物,用于治疗印度耐多药结核病治疗失败的患者。
Eur Respir J. 2012 Apr;39(4):956-62. doi: 10.1183/09031936.00076811. Epub 2011 Sep 29.
9
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.关于《每日300毫克利奈唑胺治疗难治性耐多药和广泛耐药结核病》的评论
J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.
10
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.含利奈唑胺方案治疗南非儿童耐多药结核病。
Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2.

引用本文的文献

1
Treatment outcomes among children and adolescents with extensively drug-resistant (XDR) and pre-XDR tuberculosis: Systematic review and meta-analysis.广泛耐药和准广泛耐药结核病儿童及青少年的治疗结局:系统评价与荟萃分析
PLOS Glob Public Health. 2025 Jan 29;5(1):e0003754. doi: 10.1371/journal.pgph.0003754. eCollection 2025.
2
Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs.高度耐药性肺结核儿科患者的治疗结果:新型及重新利用的二线抗结核药物的作用
J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):457-467. doi: 10.1093/jpids/piaa139.
3
Tuberculosis in Infants and Children.
婴儿和儿童结核病。
Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0037-2016.
4
The spread of drug-resistant tuberculosis in children: an Italian case series.儿童耐药结核病的传播:意大利病例系列
Epidemiol Infect. 2014 Oct;142(10):2049-56. doi: 10.1017/S0950268813003191. Epub 2013 Dec 19.
5
Filgrastim therapy in a child with neutropenia induced by linezolid.培非格司亭治疗利奈唑胺诱导的儿童中性粒细胞减少症
Int J Clin Pharm. 2013 Aug;35(4):538-41. doi: 10.1007/s11096-013-9814-8. Epub 2013 Jul 3.
6
Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.利奈唑胺在新生儿和儿科住院病房中的应用——一项回顾性多中心调查的结果。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1435-42. doi: 10.1007/s10096-011-1461-1. Epub 2011 Nov 3.
7
Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.农村南非艾滋病毒感染儿童中的广泛耐药结核病。
Int J Tuberc Lung Dis. 2010 Oct;14(10):1244-51.
8
Nervous system effects of antituberculosis therapy.抗结核治疗的神经系统影响。
CNS Drugs. 2010 Aug;24(8):655-67. doi: 10.2165/11534340-000000000-00000.